172 related articles for article (PubMed ID: 6266776)
1. Leishmaniasis recidivans treated with sodium stibogluconate.
Schewach-Millet M; Fisher BK; Semah D
Cutis; 1981 Jul; 28(1):67-8, 77, 84 passim. PubMed ID: 6266776
[TBL] [Abstract][Full Text] [Related]
2. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
Bourée P; Anciaux ML; Taugourdeau P
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
[TBL] [Abstract][Full Text] [Related]
3. On the treatment of cutaneous leishmaniasis in Egypt.
Morsy TA; Abdel Wahab RM; Essa MH; Ramadan NF; Helmy OM
J Egypt Soc Parasitol; 1986 Dec; 16(2):621-8. PubMed ID: 3023501
[No Abstract] [Full Text] [Related]
4. [Evaluation of the effectiveness and toxicity of pentostam and glucantime in the treatment of cutaneous leishmaniasis].
Sáenz RE; Paz HM; Johnson CM; Narvaez E; de Vásquez AM
Rev Med Panama; 1987 Sep; 12(3):148-57. PubMed ID: 2827242
[No Abstract] [Full Text] [Related]
5. Intradermal treatment of cutaneous leishmaniasis with two antimonial drugs.
Morsy TA; Essa MH; Aboul Anaan AM; Montasser MF
J Egypt Soc Parasitol; 1988 Jun; 18(1):341-4. PubMed ID: 2836525
[No Abstract] [Full Text] [Related]
6. [Cutaneous leishmaniasis].
Vion B
Rev Med Suisse Romande; 1989 Jun; 109(6):443-9. PubMed ID: 2547241
[No Abstract] [Full Text] [Related]
7. Recurrent cutaneous leishmaniasis: successful treatment with sodium antimony gluconate.
Aram H; el-On J
Cutis; 1986 Mar; 37(3):177-9. PubMed ID: 3007035
[TBL] [Abstract][Full Text] [Related]
8. Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony.
Sharquie KE; Al-Talib KK; Chu AC
Br J Dermatol; 1988 Jul; 119(1):53-7. PubMed ID: 2841964
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cutaneous leishmaniasis with antimony sodium gluconate.
Koerber WA; Koehn MC; Jacobs PH; Russel BJ
Arch Dermatol; 1978 Aug; 114(8):1226. PubMed ID: 209753
[No Abstract] [Full Text] [Related]
10. Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam).
Kellum RE
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 1):620-2. PubMed ID: 3021826
[TBL] [Abstract][Full Text] [Related]
11. High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis.
Marsden PD; Sampaio RN; Carvalho EM; Veiga JP; Costa JL; Llanos-Cuentas EA
Am J Trop Med Hyg; 1985 Jul; 34(4):710-3. PubMed ID: 2992304
[TBL] [Abstract][Full Text] [Related]
12. Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate.
Thakur CP; Kumar K; Sinha PK; Mishra BN; Pandey AK
Br Med J (Clin Res Ed); 1987 Oct; 295(6603):886-7. PubMed ID: 2823955
[No Abstract] [Full Text] [Related]
13. Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.
Chulay JD; Fleckenstein L; Smith DH
Trans R Soc Trop Med Hyg; 1988; 82(1):69-72. PubMed ID: 2845611
[TBL] [Abstract][Full Text] [Related]
14. [Successful treatment of antimony-resistant cutaneous leishmaniasis].
Kremsner P; Lang I; Kollaritsch H
Hautarzt; 1987 Dec; 38(12):733-5. PubMed ID: 2830206
[TBL] [Abstract][Full Text] [Related]
15. Treatment of experimental cutaneous leishmaniasis by liposome-entrapped Pentostam.
New RR; Chance ML
Acta Trop; 1980 Sep; 37(3):253-6. PubMed ID: 6106363
[No Abstract] [Full Text] [Related]
16. High-dose sodium stibogluconate treatment of cutaneous leishmaniasis in Kenya.
Chulay JD; Anzeze EM; Koech DK; Bryceson AD
Trans R Soc Trop Med Hyg; 1983; 77(5):717-21. PubMed ID: 6318408
[TBL] [Abstract][Full Text] [Related]
17. Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients.
Kager PA; Rees PH; Manguyu FM; Bhatt KM; Wellde BT; Hockmeyer WT; Lyerly WH
Trop Geogr Med; 1984 Mar; 36(1):21-35. PubMed ID: 6328709
[TBL] [Abstract][Full Text] [Related]
18. Two unusual cases of cutaneous leishmaniasis responding to pentavalent antimonials.
Vermeer BJ; van der Kaay HJ
Acta Leiden; 1983 Dec; 51():31-5. PubMed ID: 6089490
[No Abstract] [Full Text] [Related]
19. [Antimony content of the thyroid of man and animals undergoing visceral leishmaniasis treatment with the organic compound of antimony, stibogluconate sodium].
Fuzaĭlov IuM
Med Parazitol (Mosk); 1982; 51(1):62-5. PubMed ID: 6278277
[No Abstract] [Full Text] [Related]
20. Evaluation of sodium stibogluconate in the treatment of cutaneous leishmaniasis in Syria.
Ghosn S
Curr Med Res Opin; 1979; 6(4):280-3. PubMed ID: 230939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
